Roche gets US FDA approval for Evrysdi to treat spinal muscular atrophy
In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
risdiplam
Roche’s SMA drug trial win bolsters $2 billion sales prospects
US regulators are due to decide by May 24